| Dr Said Abuhasna, MD | |
|
800 Biesterfield Rd Ste 105, Elk Grove Village, IL 60007-3372 | |
| (847) 981-3660 | |
| Not Available |
| Full Name | Dr Said Abuhasna |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 37 Years |
| Location | 800 Biesterfield Rd Ste 105, Elk Grove Village, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699187344 | NPI | - | NPPES |
| 036081409 | Medicaid | IL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Trinity Hospital | Chicago, IL | Hospital |
| Methodist Hospitals Inc | Gary, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| United Elite Hospitalists Llc | 6204075112 | 21 |
| United Elite Hospitalists Llc | 6204075112 | 21 |
News Archive
Bioimpedance spectroscopy is better than a tape measure for assessing a woman's risk for developing lymphedema after breast cancer surgery, according to interim results of a study led by Sheila Ridner, PhD, RN, Martha Ingram Professor and director of the PhD in Nursing Science Program at Vanderbilt University School of Nursing.
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.
Domainex Ltd, the leading UK-based drug discovery CRO, has won the 2010 Genesis Life Science Innovation and Enterprise Programme Of The Year Award. This Award was made in recognition of Domainex's proactive work on promoting academic-industry collaborations, and was adjudicated by leading representatives of the biotechnology and pharmaceutical industries.
BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer's Disease Metabolomics Consortium's new breakthrough in Alzheimer's research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer's disease (AD). During the Alzheimer's Association International Conference, Chicago, USA, researchers reported new data on how gut bacteria and lipid metabolism may influence AD.
› Verified 1 days ago
| Entity Name | Pekin Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245355411 PECOS PAC ID: 4789676438 Enrollment ID: O20040401000798 |
News Archive
Bioimpedance spectroscopy is better than a tape measure for assessing a woman's risk for developing lymphedema after breast cancer surgery, according to interim results of a study led by Sheila Ridner, PhD, RN, Martha Ingram Professor and director of the PhD in Nursing Science Program at Vanderbilt University School of Nursing.
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.
Domainex Ltd, the leading UK-based drug discovery CRO, has won the 2010 Genesis Life Science Innovation and Enterprise Programme Of The Year Award. This Award was made in recognition of Domainex's proactive work on promoting academic-industry collaborations, and was adjudicated by leading representatives of the biotechnology and pharmaceutical industries.
BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer's Disease Metabolomics Consortium's new breakthrough in Alzheimer's research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer's disease (AD). During the Alzheimer's Association International Conference, Chicago, USA, researchers reported new data on how gut bacteria and lipid metabolism may influence AD.
› Verified 1 days ago
| Entity Name | United Elite Hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912279050 PECOS PAC ID: 6204075112 Enrollment ID: O20130625000212 |
News Archive
Bioimpedance spectroscopy is better than a tape measure for assessing a woman's risk for developing lymphedema after breast cancer surgery, according to interim results of a study led by Sheila Ridner, PhD, RN, Martha Ingram Professor and director of the PhD in Nursing Science Program at Vanderbilt University School of Nursing.
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.
Domainex Ltd, the leading UK-based drug discovery CRO, has won the 2010 Genesis Life Science Innovation and Enterprise Programme Of The Year Award. This Award was made in recognition of Domainex's proactive work on promoting academic-industry collaborations, and was adjudicated by leading representatives of the biotechnology and pharmaceutical industries.
BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer's Disease Metabolomics Consortium's new breakthrough in Alzheimer's research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer's disease (AD). During the Alzheimer's Association International Conference, Chicago, USA, researchers reported new data on how gut bacteria and lipid metabolism may influence AD.
› Verified 1 days ago
| Entity Name | Cep America Illinois Intensivists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821641499 PECOS PAC ID: 0345535449 Enrollment ID: O20160829002157 |
News Archive
Bioimpedance spectroscopy is better than a tape measure for assessing a woman's risk for developing lymphedema after breast cancer surgery, according to interim results of a study led by Sheila Ridner, PhD, RN, Martha Ingram Professor and director of the PhD in Nursing Science Program at Vanderbilt University School of Nursing.
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.
Domainex Ltd, the leading UK-based drug discovery CRO, has won the 2010 Genesis Life Science Innovation and Enterprise Programme Of The Year Award. This Award was made in recognition of Domainex's proactive work on promoting academic-industry collaborations, and was adjudicated by leading representatives of the biotechnology and pharmaceutical industries.
BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer's Disease Metabolomics Consortium's new breakthrough in Alzheimer's research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer's disease (AD). During the Alzheimer's Association International Conference, Chicago, USA, researchers reported new data on how gut bacteria and lipid metabolism may influence AD.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Said Abuhasna, MD 800 Biesterfield Rd, Suite 105, Elk Grove Village, IL 60007 Ph: (847) 981-3660 | Dr Said Abuhasna, MD 800 Biesterfield Rd Ste 105, Elk Grove Village, IL 60007-3372 Ph: (847) 981-3660 |
News Archive
Bioimpedance spectroscopy is better than a tape measure for assessing a woman's risk for developing lymphedema after breast cancer surgery, according to interim results of a study led by Sheila Ridner, PhD, RN, Martha Ingram Professor and director of the PhD in Nursing Science Program at Vanderbilt University School of Nursing.
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.
Domainex Ltd, the leading UK-based drug discovery CRO, has won the 2010 Genesis Life Science Innovation and Enterprise Programme Of The Year Award. This Award was made in recognition of Domainex's proactive work on promoting academic-industry collaborations, and was adjudicated by leading representatives of the biotechnology and pharmaceutical industries.
BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer's Disease Metabolomics Consortium's new breakthrough in Alzheimer's research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer's disease (AD). During the Alzheimer's Association International Conference, Chicago, USA, researchers reported new data on how gut bacteria and lipid metabolism may influence AD.
› Verified 1 days ago
Michael James Keller, M.D. Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 510, Elk Grove Village, IL 60007 Phone: 847-981-3660 Fax: 847-956-5108 | |
Dr. Barry Glick, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 810 Biesterfield Rd, Suite 306, Elk Grove Village, IL 60007 Phone: 847-981-6061 Fax: 847-981-6062 | |
Dr. Bhupinder K Chhabra, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 3007, Elk Grove Village, IL 60007 Phone: 847-290-6513 Fax: 847-290-8505 | |
Anshul Aggarwal, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd Ste G01, Elk Grove Village, IL 60007 Phone: 847-981-3680 | |
Edward J Diamond, M.D. Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 510, Elk Grove Village, IL 60007 Phone: 847-981-3660 Fax: 847-956-5108 | |
Anurag Mehrotra, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd Ste 510, Elk Grove Village, IL 60007 Phone: 847-981-3660 | |
Nephtali Kogan, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd Ste G01, Elk Grove Village, IL 60007 Phone: 847-981-3680 |